Greg Whitehead bluebird bio

Greg Whitehead is the Senior Director of Quality Assurance at bluebird bio, a role he assumed in 2014. He is a biotechnology professional with over 20 years of global Quality experience in vaccine, cell and gene therapy development, production and commercialization. Prior to joining bluebird bio, Greg held roles of increasing responsibility within Quality for Dendreon, Corporation. During his career, Greg has been involved with successful FDA and EMA submissions, license approvals, and clinical trial management and commercialization activities for autologous cell/gene therapy products.